Gene Summary for SEC422N1
Functional Category: inhibitor
Cell Location: extracellular
OST/GST:
Original Accession #: IPI00019272
Mouse Nucleotide Accession #: NM_024449
Human Nucleotide Accession #: NM_025237

Summary:
No summary available.

Mouse Gene Sequence Information
Nucleotide Reference: NM_024449 ACCESSION:NM_024449 NID:14209687 Mus musculus Mus musculus sclerostin (Sost), mRNA. mouse_refseq
Protein Reference: Q99P68 ACCESSION:Q99P68 NID: Mus musculus (Mouse). SCLEROSTIN PRECURSOR. MOUSESPTRNRDB
Entrez Gene: 74499

Human Gene Sequence Information
Nucleotide Reference: NM_025237 ACCESSION:NM_025237 NID:13376845 Homo sapiens Homo sapiens sclerosteosis (SOST), mRNA. hs_refseq
Protein Reference: Q9BQB4 ACCESSION:Q9BQB4 NID: Homo sapiens (Human). SCLEROSTIN PRECURSOR. HUMANSPTRNRDB
Entrez Gene: 50964

Bibliographic References
Title Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST).
Author[s] Balemans W, Ebeling M, Patel N, Van Hul E, Olson P, Dioszegi M, Lacza C, Wuyts W, Van Den Ende J, Willems P, Paes-Alves AF, Hill S, Bueno M, Ramos FJ, Tacconi P, Dikkers FG, Stratakis C, Lindpaintner K, Vickery B, Foernzler D, Van Hul W
Journal Hum Mol Genet. 03-1-2001; 10:537-43

Title Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein.
Author[s] Brunkow ME, Gardner JC, Van Ness J, Paeper BW, Kovacevich BR, Proll S, Skonier JE, Zhao L, Sabo PJ, Fu Y, Alisch RS, Gillett L, Colbert T, Tacconi P, Galas D, Hamersma H, Beighton P, Mulligan J
Journal Am J Hum Genet. 03-2001; 68:577-89

Title Sclerostin Is an Osteocyte-expressed Negative Regulator of Bone Formation, But Not a Classical BMP Antagonist.
Author[s] Van Bezooijen Rutger L, Roelen Bernard A J, Visser Annemieke, Van Der Wee-Pals Lianne, De Wilt Edwin, Karperien Marcel, Hamersma Herman, Papapoulos Socrates E, Ten Dijke Peter, L¿wik Clemens W G M
Journal J Exp Med. 03/15/2004; 199:805-14

Title Sclerostin is a novel secreted osteoclast-derived bone morphogenetic protein antagonist with unique ligand specificity.
Author[s] Kusu Naoki, Laurikkala Johanna, Imanishi Mayumi, Usui Hiroko, Konishi Morichika, Miyake Ayumi, Thesleff Irma, Itoh Nobuyuki
Journal J Biol Chem. 06/27/2003; 278:24113-7

Title Osteocyte control of bone formation via sclerostin, a novel BMP antagonist.
Author[s] Winkler David G, Sutherland May Kung, Geoghegan James C, Yu Changpu, Hayes Trenton, Skonier John E, Shpektor Diana, Jonas Mechtild, Kovacevich Brian R, Staehling-Hampton Karen, Appleby Mark, Brunkow Mary E, Latham John A
Journal EMBO J. 12/01/2003; 22:6267-76

Mutation Information
Mutation Type: Homologous Recombination (standard)
Description: Coding exons 1 and 2 were targeted (NCBI accession AK017295.1).



Copyright 2010 by Lexicon Pharmaceuticals, Inc.